Virgínia Martins Carvalho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Virgínia Martins Carvalho has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Ernesto Díaz Rocha
Faculdade de Farmácia Universidade Federal do Rio de Janeiro Rio de Janeiro Brazil
3 shared publications - Fernando Gomes de Almeida
Polícia Civil do Estado do Rio de Janeiro
2 shared publications - Robert Michael Strongin
Portland State University
2 shared publications - Alinny R. Isaac
Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941902, Brazil
1 shared publication - Ana Cláudia de Macêdo Vieira
Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho, 373, Cidade Universitária, CEP 21941-170 Rio de Janeiro, RJ, Brazil
1 shared publication - Ana Cláudia de Macêdo Vieira
Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Wiley in Journal of Neurochemistry
- Vol. 170 (9)
Adolescent Exposure to a THC ‐Rich Cannabis Extract Produces Genotype‐Dependent Effects on Cognition and Glial Morphology in Serine Racemase Mutant Mice
Adolescent cannabis exposure has been associated with an increased risk of schizophrenia; however, how genetic vulnerability shapes the long‐term consequences of adolescent cannabinoid exposure remains poorly understood. Δ 9 ‐Tetrahydrocannabinol (THC), the principal psychoactive constituent of cannabis and the predominant cannabinoid in the THC‐rich cannabis extract used here, primarily activates cannabinoid type 1 receptors (CB1). In parallel, reduced availability of D‐serine, an endogenous co‐agonist of N‐methyl‐D‐aspartate receptors (NMDARs), has been implicated in the pathophysiology of schizophrenia. Here, we investigated whether adolescent exposure to a THC‐rich cannabis extract modulated long‐term behavioral, neurochemical, and glial outcomes in serine racemase mutant (SrrY269*) mice, a genetic model characterized by reduced D‐serine levels and schizophrenia‐relevant phenotypes. Mice received escalating oral doses of the THC‐rich cannabis extract during adolescence and were evaluated in adulthood using behavioral assays, amino acid quantification, and glial morphometric analyses. Adolescent exposure to the THC‐rich cannabis extract prevented deficits in prepulse inhibition and spatial object recognition memory in adult SrrY269* mice, while transiently impairing sensorimotor gating in wild‐type animals. Irrespective of genotype, mice exposed to the THC‐rich cannabis extract spent more time in the center of the open field in adulthood. In behaviorally tested SrrY269* mice, reduced hippocampal microglial branching was attenuated following adolescent treatment. In an independent behavior‐naïve cohort, SrrY269* mice exhibited marked astrocytic morphological alterations, several of which were also attenuated by adolescent exposure to the THC‐rich cannabis extract. In contrast, the same treatment induced a distinct astrocytic phenotype in wild‐type mice. Adolescent exposure to the THC‐rich cannabis extract did not alter hippocampal or prefrontal cortical levels of D‐serine or other amino acids involved in NMDAR signaling in adulthood. These findings indicate that adolescent exposure to a THC‐rich cannabis extract produces genotype‐dependent long‐term effects, preventing specific behavioral deficits and attenuating independently assessed microglial and astrocytic alterations in SrrY269* mice, while producing adverse behavioral and astrocytic outcomes in wild‐type animals. Genetic background may therefore be an important determinant of the long‐term neurodevelopmental consequences of adolescent exposure to THC‐rich cannabis extracts. image
- 25 September 2026
- Published by Wiley in Journal of Neurochemistry
- Vol. 170 (9)
Open AccessAdolescent Exposure to a THC ‐Rich Cannabis Extract Produces Genotype‐Dependent Effects on Cognition and Glial Morphology in Serine Racemase Mutant Mice
Adolescent cannabis exposure has been associated with an increased risk of schizophrenia; however, how genetic vulnerability shapes the long‐term consequences of adolescent cannabinoid exposure remains poorly understood. Δ 9 ‐Tetrahydrocannabinol (THC), the principal psychoactive constituent of cannabis and the predominant cannabinoid in the THC‐rich cannabis extract used here, primarily activates cannabinoid type 1 receptors (CB1). In parallel, reduced availability of D‐serine, an endogenous co‐agonist of N‐methyl‐D‐aspartate receptors (NMDARs), has been implicated in the pathophysiology of schizophrenia. Here, we investigated whether adolescent exposure to a THC‐rich cannabis extract modulated long‐term behavioral, neurochemical, and glial outcomes in serine racemase mutant (SrrY269*) mice, a genetic model characterized by reduced D‐serine levels and schizophrenia‐relevant phenotypes. Mice received escalating oral doses of the THC‐rich cannabis extract during adolescence and were evaluated in adulthood using behavioral assays, amino acid quantification, and glial morphometric analyses. Adolescent exposure to the THC‐rich cannabis extract prevented deficits in prepulse inhibition and spatial object recognition memory in adult SrrY269* mice, while transiently impairing sensorimotor gating in wild‐type animals. Irrespective of genotype, mice exposed to the THC‐rich cannabis extract spent more time in the center of the open field in adulthood. In behaviorally tested SrrY269* mice, reduced hippocampal microglial branching was attenuated following adolescent treatment. In an independent behavior‐naïve cohort, SrrY269* mice exhibited marked astrocytic morphological alterations, several of which were also attenuated by adolescent exposure to the THC‐rich cannabis extract. In contrast, the same treatment induced a distinct astrocytic phenotype in wild‐type mice. Adolescent exposure to the THC‐rich cannabis extract did not alter hippocampal or prefrontal cortical levels of D‐serine or other amino acids involved in NMDAR signaling in adulthood. These findings indicate that adolescent exposure to a THC‐rich cannabis extract produces genotype‐dependent long‐term effects, preventing specific behavioral deficits and attenuating independently assessed microglial and astrocytic alterations in SrrY269* mice, while producing adverse behavioral and astrocytic outcomes in wild‐type animals. Genetic background may therefore be an important determinant of the long‐term neurodevelopmental consequences of adolescent exposure to THC‐rich cannabis extracts. image
- Open Access
- 21 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (14) , 11775
Long-Term Treatment with Cannabidiol-Enriched Cannabis Extract Induces Synaptic Changes in the Adolescent Rat Hippocampus
The endocannabinoid system (eCS) is widely distributed in mammalian tissues and it is classically formed by cannabinoid receptors, endogenous bioactive lipids and its synthesis and degradation enzymes. Due to the modulatory role of eCS in synaptic activity in the Central Nervous System (CNS), phytocannabinoids have been increasingly used for the treatment of neurological disorders, even though little is known in terms of the long-term effect of these treatments on CNS development, mainly in the timeframe that comprises childhood and adolescence. Furthermore, an increased number of clinical trials using full-spectrum Cannabis extracts has been seen, rather than the isolated form of phytocannabinoids, when exploring the therapeutical benefits of the Cannabis plant. Thus, this study aims to evaluate the effect of cannabidiol (CBD)-enriched Cannabis extract on synaptic components in the hippocampus of rats from adolescence to early adulthood (postnatal day 45 to 60). Oral treatment of healthy male Wistar rats with a CBD-enriched Cannabis extract (3 mg/kg/day CBD) during 15 days did not affect food intake and water balance. There was also no negative impact on locomotor behaviour and cognitive performance. However, the hippocampal protein levels of GluA1 and GFAP were reduced in animals treated with the extract, whilst PSD95 levels were increased, which suggests rearrangement of glutamatergic synapses and modulation of astrocytic features. Microglial complexity was reduced in CA1 and CA3 regions, but no alterations in their phagocytic activity have been identified by Iba-1 and LAMP2 co-localization. Collectively, our data suggest that CBD-enriched Cannabis treatment may be safe and well-tolerated in healthy subjects, besides acting as a neuroprotective agent against hippocampal alterations related to the pathogenesis of excitatory and astrogliosis-mediated disorders in CNS.
- 21 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (14) , 11775
Open AccessLong-Term Treatment with Cannabidiol-Enriched Cannabis Extract Induces Synaptic Changes in the Adolescent Rat Hippocampus
The endocannabinoid system (eCS) is widely distributed in mammalian tissues and it is classically formed by cannabinoid receptors, endogenous bioactive lipids and its synthesis and degradation enzymes. Due to the modulatory role of eCS in synaptic activity in the Central Nervous System (CNS), phytocannabinoids have been increasingly used for the treatment of neurological disorders, even though little is known in terms of the long-term effect of these treatments on CNS development, mainly in the timeframe that comprises childhood and adolescence. Furthermore, an increased number of clinical trials using full-spectrum Cannabis extracts has been seen, rather than the isolated form of phytocannabinoids, when exploring the therapeutical benefits of the Cannabis plant. Thus, this study aims to evaluate the effect of cannabidiol (CBD)-enriched Cannabis extract on synaptic components in the hippocampus of rats from adolescence to early adulthood (postnatal day 45 to 60). Oral treatment of healthy male Wistar rats with a CBD-enriched Cannabis extract (3 mg/kg/day CBD) during 15 days did not affect food intake and water balance. There was also no negative impact on locomotor behaviour and cognitive performance. However, the hippocampal protein levels of GluA1 and GFAP were reduced in animals treated with the extract, whilst PSD95 levels were increased, which suggests rearrangement of glutamatergic synapses and modulation of astrocytic features. Microglial complexity was reduced in CA1 and CA3 regions, but no alterations in their phagocytic activity have been identified by Iba-1 and LAMP2 co-localization. Collectively, our data suggest that CBD-enriched Cannabis treatment may be safe and well-tolerated in healthy subjects, besides acting as a neuroprotective agent against hippocampal alterations related to the pathogenesis of excitatory and astrogliosis-mediated disorders in CNS.
- 2 June 2023
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 33 (4) , 724-735
Pharmaceutical Evaluation of Medical Cannabis Extracts Prepared by Artisanal and Laboratory Techniques
- 2 June 2023
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 33 (4) , 724-735
Pharmaceutical Evaluation of Medical Cannabis Extracts Prepared by Artisanal and Laboratory Techniques
- 14 April 2022
- Published by Elsevier in Forensic Science International
- Vol. 335, 111309
Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil
- 14 April 2022
- Published by Elsevier in Forensic Science International
- Vol. 335, 111309
Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil
- 23 June 2021
- Published by Brazilian Journal of Analytical Chemistry in Brazilian Journal of Analytical Chemistry
- Vol. 9 (34) , 162-176
Facing the Forensic Challenge of Cannabis Regulation: A Methodology for the Differentiation between Hemp and Marijuana Samples / Presumptive and confirmatory methods for hemp and marijuana analysis
Access to medical and recreational cannabis has been regulated in several countries. Cannabinoids are secondary metabolites used as chemical markers of Cannabis genus plants. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most abundant cannabinoids and their proportion is used to differentiate hemp (THC/CBD1) varieties. Brazilian sanitary regulations permit prescription, importation and sale of cannabis-derived products by pharmaceuticals distributors and drugstores, even though their crops are still prohibited, and the current scenario is characterized by marijuana trafficking, legal trade of medical cannabis products, and cultivation and production of cannabis-derived products by patients and non-governmental organizations (NGOs), with or without judicial authorizations. Medical cannabis regulation is in progress and there is an urgent need to implement analytical methods for monitoring the chemical profile of cannabis crops. Thus, the goal of the present study was to propose a methodology based on presumptive and confirmatory methods to differentiate the two principal chemovars of Cannabis genus plants, i.e., CBD-rich (hemp) and THC-rich (marijuana). A color test and a validated high-performance liquid chromatography (HPLC) method were applied to six cannabis samples cultivated by patients with judicial authorization. The methodology proved to be useful for forensic purposes and for quality control of medical cannabis. Plants cultivated by patients showed three profiles, classified as THC-rich, CBD-rich and approximately 1:1 THC/CBD ratio.
- 23 June 2021
- Published by Brazilian Journal of Analytical Chemistry in Brazilian Journal of Analytical Chemistry
- Vol. 9 (34) , 162-176
Facing the Forensic Challenge of Cannabis Regulation: A Methodology for the Differentiation between Hemp and Marijuana Samples / Presumptive and confirmatory methods for hemp and marijuana analysis
Access to medical and recreational cannabis has been regulated in several countries. Cannabinoids are secondary metabolites used as chemical markers of Cannabis genus plants. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most abundant cannabinoids and their proportion is used to differentiate hemp (THC/CBD1) varieties. Brazilian sanitary regulations permit prescription, importation and sale of cannabis-derived products by pharmaceuticals distributors and drugstores, even though their crops are still prohibited, and the current scenario is characterized by marijuana trafficking, legal trade of medical cannabis products, and cultivation and production of cannabis-derived products by patients and non-governmental organizations (NGOs), with or without judicial authorizations. Medical cannabis regulation is in progress and there is an urgent need to implement analytical methods for monitoring the chemical profile of cannabis crops. Thus, the goal of the present study was to propose a methodology based on presumptive and confirmatory methods to differentiate the two principal chemovars of Cannabis genus plants, i.e., CBD-rich (hemp) and THC-rich (marijuana). A color test and a validated high-performance liquid chromatography (HPLC) method were applied to six cannabis samples cultivated by patients with judicial authorization. The methodology proved to be useful for forensic purposes and for quality control of medical cannabis. Plants cultivated by patients showed three profiles, classified as THC-rich, CBD-rich and approximately 1:1 THC/CBD ratio.
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Rodriguésia
- Vol. 71
Qualitative terpene profiling of Cannabis varieties cultivated for medical purposes
With the upcoming medical Cannabis regulation, quality control methods on raw material will be required. Besides testing for contaminants and potency, there are also pharmaceutical and forensic interests in the determination of the terpene profile in different strains of Cannabis as complementary identification methods. A simple non-destructive HS-SPME GC-MS method was used to identify the terpene content in twelve Cannabis samples, four of them were of the hemp type (Harle-tsu), seven from various marihuana types and one of the intermediate type. They all were previously analyzed by HPLC to determine the potency (THC and CBD content). Spectral library matching was used to identify the terpenes compounds. Thirty terpenes compounds were detected, nine of them were present in all Cannabis samples and used to find their terpene profile: α-pinene, β-pinene, β-myrcene, D-limonene, terpinolene, linalool, caryophyllene, α-bergamotene and humulene. Three of them, caryophyllene, α-pinene and β-myrcene were found as larger components in most of samples. A principal components analyses (PCA) was performed. The four hemp type samples showed two different profiles, two samples showed caryophyllene as main component and the others two with β-myrcene as such. The marihuana type samples showed wider profiles with no clear patterns at all, which is not surprising because of the low number of samples. The simple methodology shows viable to set the terpenes profile for analyses of raw Cannabis material. Suitability for differentiation between different sorts of types needs more studies, with increasing numbers of samples.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Rodriguésia
- Vol. 71
Open AccessQualitative terpene profiling of Cannabis varieties cultivated for medical purposes
With the upcoming medical Cannabis regulation, quality control methods on raw material will be required. Besides testing for contaminants and potency, there are also pharmaceutical and forensic interests in the determination of the terpene profile in different strains of Cannabis as complementary identification methods. A simple non-destructive HS-SPME GC-MS method was used to identify the terpene content in twelve Cannabis samples, four of them were of the hemp type (Harle-tsu), seven from various marihuana types and one of the intermediate type. They all were previously analyzed by HPLC to determine the potency (THC and CBD content). Spectral library matching was used to identify the terpenes compounds. Thirty terpenes compounds were detected, nine of them were present in all Cannabis samples and used to find their terpene profile: α-pinene, β-pinene, β-myrcene, D-limonene, terpinolene, linalool, caryophyllene, α-bergamotene and humulene. Three of them, caryophyllene, α-pinene and β-myrcene were found as larger components in most of samples. A principal components analyses (PCA) was performed. The four hemp type samples showed two different profiles, two samples showed caryophyllene as main component and the others two with β-myrcene as such. The marihuana type samples showed wider profiles with no clear patterns at all, which is not surprising because of the low number of samples. The simple methodology shows viable to set the terpenes profile for analyses of raw Cannabis material. Suitability for differentiation between different sorts of types needs more studies, with increasing numbers of samples.
- 1 January 2017
- Published by OpenEdition in Forum Sociológico
- Vol. 30 (30) , 57-66
Mães pela cannabis medicinal em um Brasil aterrorizado entre luzes e fantasmas
Desde a proibição da planta Cannabis sativa L. (cannabis ou maconha), diversos estudos científicos vêm sendo publicados demonstrando tanto os riscos à saúde do uso social como as evidências que embasam o uso farmacêutico. Acompanhando a ciência, ativistas têm se organizado pleiteando a regulação do uso social à semelhança das drogas lícitas como álcool e tabaco. No entanto, nem a ciência nem o movimento ativista pela legalização puderam sozinhos impingir tamanha revolução na regulação sanitária brasileira como a que vem sendo liderada por mulheres/mães que adotaram a desobediência civil pacífica como estratégia para garantir o direito à saúde e qualidade de vida de seus filhos. Este artigo trata desse movimento feminino e materno que tem transformado a realidade com auxílio das tecnologias digitais e impulsionado instituições públicasa se voltarem ao tema.
- 1 January 2017
- Published by OpenEdition in Forum Sociológico
- Vol. 30 (30) , 57-66
Mães pela cannabis medicinal em um Brasil aterrorizado entre luzes e fantasmas
Desde a proibição da planta Cannabis sativa L. (cannabis ou maconha), diversos estudos científicos vêm sendo publicados demonstrando tanto os riscos à saúde do uso social como as evidências que embasam o uso farmacêutico. Acompanhando a ciência, ativistas têm se organizado pleiteando a regulação do uso social à semelhança das drogas lícitas como álcool e tabaco. No entanto, nem a ciência nem o movimento ativista pela legalização puderam sozinhos impingir tamanha revolução na regulação sanitária brasileira como a que vem sendo liderada por mulheres/mães que adotaram a desobediência civil pacífica como estratégia para garantir o direito à saúde e qualidade de vida de seus filhos. Este artigo trata desse movimento feminino e materno que tem transformado a realidade com auxílio das tecnologias digitais e impulsionado instituições públicasa se voltarem ao tema.